Aristotle Capital Management, LLC Jazz Pharmaceuticals PLC Transaction History
Aristotle Capital Management, LLC
- $51.7 Billion
- Q3 2024
A detailed history of Aristotle Capital Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Aristotle Capital Management, LLC holds 212,691 shares of JAZZ stock, worth $25.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
212,691
Previous 197,236
7.84%
Holding current value
$25.7 Million
Previous $21.1 Million
12.62%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding JAZZ
# of Institutions
511Shares Held
57.6MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$743 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$738 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$301 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$268 Million0.67% of portfolio
-
State Street Corp Boston, MA1.95MShares$235 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.57B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...